Abstract
Topical 5-fluorouracil has been used as an effective treatment for porokeratosis. Upon its treatment, an inflammatory effect occurs with the topical 5-fluorouracil. We report a case of a patient with disseminated superficial actinic porokeratosis displaying a comparable inflammatory process following therapy with systemic 5-fluorouracil used to manage a metastatic breast cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 190-192 |
| Number of pages | 3 |
| Journal | Journal of the European Academy of Dermatology and Venereology |
| Volume | 17 |
| Issue number | 2 |
| DOIs | |
| State | Published - Mar 1 2003 |
| Externally published | Yes |
Fingerprint
Keywords
- 5-fluorouracil
- Actinic keratosis
- Chemotherapy
- Porokeratosis
ASJC Scopus subject areas
- Dermatology
- Infectious Diseases
Cite this
Systemic 5-fluorouracil producing an inflammatory response in porokeratosis. / Nahm, W. K.; Donohue, K. G.; Danahy, J. F.; Badiavas, Evangelos V; Falanga, V.
In: Journal of the European Academy of Dermatology and Venereology, Vol. 17, No. 2, 01.03.2003, p. 190-192.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Systemic 5-fluorouracil producing an inflammatory response in porokeratosis
AU - Nahm, W. K.
AU - Donohue, K. G.
AU - Danahy, J. F.
AU - Badiavas, Evangelos V
AU - Falanga, V.
PY - 2003/3/1
Y1 - 2003/3/1
N2 - Topical 5-fluorouracil has been used as an effective treatment for porokeratosis. Upon its treatment, an inflammatory effect occurs with the topical 5-fluorouracil. We report a case of a patient with disseminated superficial actinic porokeratosis displaying a comparable inflammatory process following therapy with systemic 5-fluorouracil used to manage a metastatic breast cancer.
AB - Topical 5-fluorouracil has been used as an effective treatment for porokeratosis. Upon its treatment, an inflammatory effect occurs with the topical 5-fluorouracil. We report a case of a patient with disseminated superficial actinic porokeratosis displaying a comparable inflammatory process following therapy with systemic 5-fluorouracil used to manage a metastatic breast cancer.
KW - 5-fluorouracil
KW - Actinic keratosis
KW - Chemotherapy
KW - Porokeratosis
UR - http://www.scopus.com/inward/record.url?scp=0037357682&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037357682&partnerID=8YFLogxK
U2 - 10.1046/j.1468-3083.2003.00575.x
DO - 10.1046/j.1468-3083.2003.00575.x
M3 - Article
C2 - 12705749
AN - SCOPUS:0037357682
VL - 17
SP - 190
EP - 192
JO - Journal of the European Academy of Dermatology and Venereology
JF - Journal of the European Academy of Dermatology and Venereology
SN - 0926-9959
IS - 2
ER -